Allscripts Hlthcare (MDRX)

$15.30 0.42 (2.67%)

16:00 EDT MDRX Stock Quote Delayed 30 Minutes

7 Healthcare Stocks That Can Survive Massive Reform

By Tezcan Gecgil, InvestorPlace Contributor Nov 2, 2020

These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election.

7 Best Tech Stock Ideas for 2018

Earnings Visibility Hamper Allscripts Healthcare Solutions (MDRX) Rating

Allscripts Healthcare Solutions (MDRX) Shares Raised to Hold

Volume:

Previous Close -

Market Cap 1.70B

PE Ratio 39.23

EPS 0.39

Volume (Avg. Vol.) 1.77M

Day's Range $15.21 - $15.72

52-Week Range $13.05 - $23.24

Dividend & Yield N/A (N/A)

MDRX Stock Predictions, Articles, and Allscripts Hlthcare News

From InvestorPlace
From the Web

Quant Score Metrics Restrict Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to Hold

By Portfolio Grader Nov 23, 2017

Allscripts Healthcare Solutions (NASDAQ:MDRX) is ranked as a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. MDRX has been upgraded from a Sell to a Hold in the last week.

Falling Earnings Visibility Keep Allscripts Healthcare Solutions (MDRX) a Sell

By Portfolio Grader Nov 16, 2017

Currently, Allscripts Healthcare Solutions (NASDAQ:MDRX) has a Sell using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking MDRX has had from Portfolio Grader for 3 months.

Quant Score Analytics Keep Allscripts Healthcare Solutions (MDRX) Ratings Upgrade to Hold

By Portfolio Grader Nov 9, 2017

Allscripts Healthcare Solutions (NASDAQ:MDRX) is ranked as a Hold using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The shares have been upgraded from a Sell to a Hold in the last week.

Analysis of Earnings Growth Makes Allscripts Healthcare Solutions (MDRX) a Sell

By Portfolio Grader Nov 2, 2017

Allscripts Healthcare Solutions (NASDAQ:MDRX) is a $2.5 billion in market value component of the Health Care Technology GICS industry group where the current Portfolio Grader ranking for MDRX puts it 20 among the 25 companies in this industry group, a position that is well below-average. MDRX is ranked in the third quartile of the sector with a ranking of 573 among the 783 companies in the sector and number 3,718 in the 5000 company Portfolio Grader company universe.

Earnings Growth Keeps Allscripts Healthcare Solutions (MDRX) a Sell

By Portfolio Grader Oct 26, 2017

Currently, Allscripts Healthcare Solutions (NASDAQ:MDRX) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. This represents no change from the previous week and is the same ranking MDRX has had from Portfolio Grader for 2 months.

Analysis of Earnings Visibility Keeps Allscripts Healthcare Solutions (MDRX) a Sell

By Portfolio Grader Oct 19, 2017

Allscripts Healthcare Solutions (NASDAQ:MDRX) is classified as a constituent of the 26 company Health Care Technology GICS industry group, which is a segment of the 783 company GICS Health Care sector. MDRX has a market value of $2.5 billion which is in the upper half of its industry group. The stock's current Portfolio Grader ranking places it 20 among the 26 companies in this industry group, a position that is well below-average; in the third quartile of the sector with a ranking of 558 among the 783 companies in the sector, and number 3,653 in the nearly 5,000 company Portfolio Grader universe.

Sell Rating on Allscripts Healthcare Solutions (MDRX) Shares Kept

By Portfolio Grader Oct 12, 2017

Allscripts Healthcare Solutions (NASDAQ:MDRX) is ranked as a Sell using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for the last month.